KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcosa (ACA) Cash & Equivalents (2017 - 2025)

Arcosa (ACA) has disclosed Cash & Equivalents for 9 consecutive years, with $214.6 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents rose 14.58% to $214.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $214.6 million through Dec 2025, up 14.58% year-over-year, with the annual reading at $214.6 million for FY2025, 14.58% up from the prior year.
  • Cash & Equivalents hit $214.6 million in Q4 2025 for Arcosa, down from $220.0 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $756.8 million in Q3 2024 to a low of $66.1 million in Q3 2021.
  • Historically, Cash & Equivalents has averaged $169.2 million across 5 years, with a median of $152.2 million in 2023.
  • Biggest five-year swings in Cash & Equivalents: soared 387.31% in 2024 and later plummeted 70.93% in 2025.
  • Year by year, Cash & Equivalents stood at $72.9 million in 2021, then skyrocketed by 120.03% to $160.4 million in 2022, then tumbled by 34.66% to $104.8 million in 2023, then soared by 78.72% to $187.3 million in 2024, then grew by 14.58% to $214.6 million in 2025.
  • Business Quant data shows Cash & Equivalents for ACA at $214.6 million in Q4 2025, $220.0 million in Q3 2025, and $189.7 million in Q2 2025.